Urological Cancers
Urological cancers are a group of cancers that affect the organs of the urinary system and the male reproductive system. These include cancers of the prostate, bladder, kidneys, testes, penis, and upper urinary tract. Collectively, they are among the most common cancers diagnosed worldwide, particularly in men.
Early diagnosis is extremely important, as many urological cancers are highly treatable when detected at an early stage. Advances in screening, imaging, minimally invasive surgery, robotic-assisted procedures, immunotherapy, and targeted treatments have significantly improved outcomes for many patients.
What are Urological Cancers?
Urological cancers develop when abnormal cells grow uncontrollably within the urinary tract or male reproductive organs. The most common types include:
- Prostate cancer – the most frequently diagnosed cancer in men.
- Bladder cancer – often linked to smoking and certain workplace chemical exposures.
- Kidney cancer – usually develops within the kidney tissue itself.
- Testicular cancer – most commonly affects younger men between the ages of 15 and 45.
- Penile cancer – a rare cancer affecting the skin and tissues of the penis.
- Upper tract urothelial cancer (UTUC) – affects the lining of the kidneys and ureters.
Each cancer behaves differently and requires an individualised approach to diagnosis and treatment.
What are the Symptoms of Urological Cancers?
Symptoms vary depending on the organ involved. Many early-stage cancers cause few or no symptoms, which is why routine screening and prompt investigation of concerning signs are important.
Common symptoms may include:
- Blood in the urine (haematuria)
- Difficulty passing urine
- Frequent urination, especially at night
- Pain or burning during urination
- A weak or interrupted urinary stream
- Pelvic pain
- Persistent lower back or flank pain
- A lump or swelling in the testicle
- Blood in the semen
- Erectile dysfunction
- Unexplained weight loss
- Fatigue
- Bone pain in advanced prostate cancer
Any persistent urinary symptoms or visible blood in the urine should always be assessed by a urologist.
What Causes Urological Cancers?
While the exact cause is often unknown, several factors can increase the likelihood of developing urological cancers.
These risk factors include:
- Increasing age
- Smoking
- Family history of prostate, bladder or kidney cancer
- Certain inherited genetic conditions
- Exposure to industrial chemicals
- Long-term bladder irritation or chronic infections
- Obesity
- High blood pressure
- Previous radiation therapy
- Human papillomavirus (HPV) infection, particularly in penile cancer
- Undescended testicle, which increases the risk of testicular cancer
Having one or more risk factors does not necessarily mean someone will develop cancer.
How are Urological Cancers Diagnosed?
Diagnosis begins with a detailed medical history and physical examination, followed by investigations tailored to the suspected condition.
These may include:
- Urine analysis and urine cytology
- Blood tests, including prostate-specific antigen (PSA) testing
- Ultrasound scans
- CT scans
- MRI scans
- PET scans in selected cases
- Flexible cystoscopy to examine the bladder
- Prostate biopsy, including MRI fusion biopsy where appropriate
- Kidney biopsy in selected cases
- Testicular ultrasound
- Bone scans for advanced prostate cancer
- Tissue biopsy to confirm the diagnosis
Once cancer has been confirmed, additional imaging may be performed to determine whether it has spread and to establish its stage.
What are the Treatment Options for Urological Cancers?
Treatment depends on the type of cancer, its stage, overall health, and individual patient preferences. A multidisciplinary team works together to develop the most appropriate treatment plan.
Treatment options may include:
- Active surveillance for selected low-risk cancers
- Robotic-assisted surgery
- Open surgery where appropriate
- Partial or radical nephrectomy for kidney cancer
- Radical prostatectomy for prostate cancer
- Radical or simple cystectomy for bladder cancer
- Transurethral resection of bladder tumours (TURBT)
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Hormone therapy for prostate cancer
- Radiotherapy
- Intravesical treatments for certain bladder cancers
- Clinical trials where appropriate
Many patients benefit from a combination of treatments depending on the characteristics of their cancer.
Advances in robotic-assisted surgery have enabled many patients to undergo minimally invasive procedures with smaller incisions, less postoperative discomfort, shorter hospital stays, and faster recovery while maintaining excellent cancer control.
Following treatment, ongoing surveillance is essential to monitor recovery, detect any recurrence early, and manage long-term health. Follow-up commonly includes PSA monitoring, imaging, cystoscopy, blood tests, and regular reviews with your urologist. With timely diagnosis and modern treatment options, outcomes for many urological cancers continue to improve, allowing patients to maintain an excellent quality of life after treatment.